Zydus Cadila has launched Phase II clinical trials of its Covid-19 vaccine
India-based Zydus Cadila has launched Phase II clinical trials of its Covid-19 vaccine ndia-based Zydus Cadila has launched Phase II clinical trials of its Covid-19 vaccine candidate, ZyCoV-D, which showed promise in a Phase I study. The company completed dosing in the Phase I trial, where the vaccine was found to be safe and well …
Zydus Cadila has launched Phase II clinical trials of its Covid-19 vaccine Read More »
